Sen Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sen Wang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Hongsheng Guo
Department of Histology and Embryology of the Basic Medical College, Guangdong Medical University, Dongguan, Guangdong Province 523808, China
4 shared publicationsPeng Li
Department of Histology and Embryology of the Basic Medical College, Guangdong Medical University, Dongguan, Guangdong Province 523808, China
4 shared publicationsZhangquan Chen
Institute of Laboratory Medicine, Guangdong Medical University, Dongguan, Guangdong Province 523808, China
4 shared publicationsKun Wu
Institute of Laboratory Medicine, Guangdong Medical University, Dongguan, Guangdong Province 523808, China
3 shared publicationsLiudan Su
Institute of Laboratory Medicine, Guangdong Medical University, Dongguan, Guangdong Province 523808, China
3 shared publicationsPing Ouyang
Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China
3 shared publications
Latest Publications
- Open Access
- 13 February 2020
- Published by Spandidos Publications in Oncology Letters
- Vol. 19 (4) , 2639-2648
Decreased IL‑37 expression in hepatocellular carcinoma tissues and liver cancer cell lines
The role of IL‑37 in cancer is currently largely unknown. The present study aimed to investigate IL‑37 expression in hepatocellular carcinoma (HCC), paracancerous tissues (PT) and liver cancer cell lines, and their associations between IL‑37 and NF‑κB. A total of 65 HCC and 65 PT tissues were collected. The expression of IL‑37 and NF‑κB in tissues was detected by immunohistochemistry (IHC) and the data was analyzed using SPSS software. In the in vitro studies, IL‑37 gene was transfected into HepG2 and MHCC97H cell lines with Lipofectamine 3000, and the protein regulation of NF‑κB by IL‑37 was verified by immunofluorescence (IF) and western blotting. In HCC, the positive expression rates of IL‑37 and NF‑kB were 21.5 and 95.4%, respectively. In PT, strong positive staining of IL‑37and weak positive staining of NF‑κB were observed. The normal expression levels of IL‑37 and NF‑κB, the increased IL‑37 and decreased NF‑κB induced by IL‑37 gene transfection were observed through IF in cell lines. In terms of clinical significance, the difference in IL‑37 expression between HCC and PT was statistically significant (χ2=55.05; P0.05). IL‑37 overexpression downregulated the NF‑κB protein by 56.50% in HepG2 cells (P<0.05) and 30.52% in MHCC97H cells (P<0.05). In conclusion, the expression of IL‑37 in HCC and PT was specifically associated with serum AFP and tumor size, respectively. IL‑37 expression was negatively correlated with NF‑κB protein expression in HCC tissues and liver cancer cell lines.
- 13 February 2020
- Published by Spandidos Publications in Oncology Letters
- Vol. 19 (4) , 2639-2648
Open AccessDecreased IL‑37 expression in hepatocellular carcinoma tissues and liver cancer cell lines
The role of IL‑37 in cancer is currently largely unknown. The present study aimed to investigate IL‑37 expression in hepatocellular carcinoma (HCC), paracancerous tissues (PT) and liver cancer cell lines, and their associations between IL‑37 and NF‑κB. A total of 65 HCC and 65 PT tissues were collected. The expression of IL‑37 and NF‑κB in tissues was detected by immunohistochemistry (IHC) and the data was analyzed using SPSS software. In the in vitro studies, IL‑37 gene was transfected into HepG2 and MHCC97H cell lines with Lipofectamine 3000, and the protein regulation of NF‑κB by IL‑37 was verified by immunofluorescence (IF) and western blotting. In HCC, the positive expression rates of IL‑37 and NF‑kB were 21.5 and 95.4%, respectively. In PT, strong positive staining of IL‑37and weak positive staining of NF‑κB were observed. The normal expression levels of IL‑37 and NF‑κB, the increased IL‑37 and decreased NF‑κB induced by IL‑37 gene transfection were observed through IF in cell lines. In terms of clinical significance, the difference in IL‑37 expression between HCC and PT was statistically significant (χ2=55.05; P0.05). IL‑37 overexpression downregulated the NF‑κB protein by 56.50% in HepG2 cells (P<0.05) and 30.52% in MHCC97H cells (P<0.05). In conclusion, the expression of IL‑37 in HCC and PT was specifically associated with serum AFP and tumor size, respectively. IL‑37 expression was negatively correlated with NF‑κB protein expression in HCC tissues and liver cancer cell lines.
- 1 October 2019
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (20) , 568
Inhibition of human cervical cancer cell invasion by IL-37 involving runt related transcription factor 2 suppression
Background: IL-37 is a newly anti-inflammatory cytokine whose function is largely unknown in cancer. Our preliminary experiment found IL-37 could inhibit the invasion of human cervical cancer (CC) cells and influence the expression of RUNX family whose function was also unclear in CC. The present study aims to further investigate the effects of IL-37 on cell invasion and runt related transcription factor 2 (RUNX2) expression in CC cell lines. Methods: Firstly, plasmid overexpressing IL-37 or RUNX2 was transfected into Siha and C33A cells by Hilymax. Then, the effects of IL-37 on the mRNA expression of RUNX1, RUNX2 and RUNX3 gene were detected by quantitative real-time polymerase chain reaction. Protein expression was measured by Western blot and the grayscale scanning analysis. Finally, the effects of IL-37 or RUNX2 on cell invasion were tested by transwell assay. Results: IL-37 inhibited the mRNA expression of RUNX1 and RUNX2, and increased that of RUNX3 in CC cells. Among the three RUNX genes, RUNX2 showed the most significant change in mRNA expression (decreased by78.5% in Siha cells and by 61.5% in C33A cells) and thus was chosen for the following study. Overexpressed IL-37 inhibited cell invasion by 36.23% in Siha cells (PConclusions: IL-37 can significantly inhibit the cell invasion of Siha and C33A cells, which involves the suppression of RUNX2.
- 1 October 2019
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (20) , 568
Inhibition of human cervical cancer cell invasion by IL-37 involving runt related transcription factor 2 suppression
Background: IL-37 is a newly anti-inflammatory cytokine whose function is largely unknown in cancer. Our preliminary experiment found IL-37 could inhibit the invasion of human cervical cancer (CC) cells and influence the expression of RUNX family whose function was also unclear in CC. The present study aims to further investigate the effects of IL-37 on cell invasion and runt related transcription factor 2 (RUNX2) expression in CC cell lines. Methods: Firstly, plasmid overexpressing IL-37 or RUNX2 was transfected into Siha and C33A cells by Hilymax. Then, the effects of IL-37 on the mRNA expression of RUNX1, RUNX2 and RUNX3 gene were detected by quantitative real-time polymerase chain reaction. Protein expression was measured by Western blot and the grayscale scanning analysis. Finally, the effects of IL-37 or RUNX2 on cell invasion were tested by transwell assay. Results: IL-37 inhibited the mRNA expression of RUNX1 and RUNX2, and increased that of RUNX3 in CC cells. Among the three RUNX genes, RUNX2 showed the most significant change in mRNA expression (decreased by78.5% in Siha cells and by 61.5% in C33A cells) and thus was chosen for the following study. Overexpressed IL-37 inhibited cell invasion by 36.23% in Siha cells (PConclusions: IL-37 can significantly inhibit the cell invasion of Siha and C33A cells, which involves the suppression of RUNX2.
- Open Access
- 1 April 2019
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 2703-2712
IL-37 promotes cell apoptosis in cervical cancer involving Bim upregulation
Background: Growing evidence has indicated that interleukin-37 (IL-37) is a potential anticancer molecule that mainly plays an inhibiting role in different kinds of cancers, but data for the role of IL-37 on cell apoptosis in cancers remains rare. The present study aimed to explore the role of IL-37 in cell apoptosis in cervical cancer, and the involved apoptosis-related molecules. Methods: IL-37 was overexpressed by transfecting the pIRES2-EGFP-IL-37 plasmid in HeLa and C33A cells. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to detect the mRNA expression of IL-37, Bcl-2, Bax and Bim. Western blotting was performed to detect the protein expression of IL-37 and Bim. Cell apoptosis was detected by flow cytometry. Results: IL-37 upregulated the mRNA expression levels of Bim by 138.40% for HeLa (PPPPPPPPPPConclusion: IL-37 upregulated Bim in cervical cancer cells. Furthermore, IL-37 can promote cervical cancer cell apoptosis, but Bim knockdown decreased this promotion through IL-37. Thus, IL-37 can promote cervical cancer cell apoptosis, which involve the upregulation of Bim.
- 1 April 2019
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 2703-2712
Open AccessIL-37 promotes cell apoptosis in cervical cancer involving Bim upregulation
Background: Growing evidence has indicated that interleukin-37 (IL-37) is a potential anticancer molecule that mainly plays an inhibiting role in different kinds of cancers, but data for the role of IL-37 on cell apoptosis in cancers remains rare. The present study aimed to explore the role of IL-37 in cell apoptosis in cervical cancer, and the involved apoptosis-related molecules. Methods: IL-37 was overexpressed by transfecting the pIRES2-EGFP-IL-37 plasmid in HeLa and C33A cells. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to detect the mRNA expression of IL-37, Bcl-2, Bax and Bim. Western blotting was performed to detect the protein expression of IL-37 and Bim. Cell apoptosis was detected by flow cytometry. Results: IL-37 upregulated the mRNA expression levels of Bim by 138.40% for HeLa (PPPPPPPPPPConclusion: IL-37 upregulated Bim in cervical cancer cells. Furthermore, IL-37 can promote cervical cancer cell apoptosis, but Bim knockdown decreased this promotion through IL-37. Thus, IL-37 can promote cervical cancer cell apoptosis, which involve the upregulation of Bim.
- 2 April 2018
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 297 (6) , 1525-1532
Increased ZNF84 expression in cervical cancer
Purpose Little is known about ZNF84 gene. This study aims to investigate ZNF84 expression in cervical cancer (CC) and the effects of ZNF84 on CC. Materials and methods Cervical cancer tissue specimens were collected from The First People’s Hospital of Foshan. ZNF84 and Akt expression were detected by immunohistochemistry. The influence of ZNF84 on cell proliferation was detected by CCK-8 kits. The effects of ZNF84 on Akt protein and mRNA expression were detected by western blotting and qPCR, respectively. Results High expression of ZNF84 protein (80.0%) was detected within CC tissues while negative expression was found in normal cervical tissues. ZNF84 was specifically associated with tumor size (p = 0.018) and negatively associated with other indicators. Further, in squamous cell carcinoma, ZNF84 was associated with both TNM staging (p = 0.041) and tumor size (p = 0.041). In vitro, we used shZNF84 to inhibit the mRNA and protein expression of ZNF84, and showed marked inhibition of cancer cell proliferation by shZNF84. Furthermore, inhibition of ZNF84 down-regulated Akt. Ly294002 (an Akt inhibitor) decreased the cell inhibition ability of shZNF84, indicating the involvement of Akt. Finally, the relationship between ZNF84 and Akt in vivo showed positive correlation (p = 0.023). Conclusion ZNF84 expression was increased in CC tissues and associated with tumor size. ZNF84 promoted cell proliferation which might involve Akt signal.
- 2 April 2018
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 297 (6) , 1525-1532
Increased ZNF84 expression in cervical cancer
Purpose Little is known about ZNF84 gene. This study aims to investigate ZNF84 expression in cervical cancer (CC) and the effects of ZNF84 on CC. Materials and methods Cervical cancer tissue specimens were collected from The First People’s Hospital of Foshan. ZNF84 and Akt expression were detected by immunohistochemistry. The influence of ZNF84 on cell proliferation was detected by CCK-8 kits. The effects of ZNF84 on Akt protein and mRNA expression were detected by western blotting and qPCR, respectively. Results High expression of ZNF84 protein (80.0%) was detected within CC tissues while negative expression was found in normal cervical tissues. ZNF84 was specifically associated with tumor size (p = 0.018) and negatively associated with other indicators. Further, in squamous cell carcinoma, ZNF84 was associated with both TNM staging (p = 0.041) and tumor size (p = 0.041). In vitro, we used shZNF84 to inhibit the mRNA and protein expression of ZNF84, and showed marked inhibition of cancer cell proliferation by shZNF84. Furthermore, inhibition of ZNF84 down-regulated Akt. Ly294002 (an Akt inhibitor) decreased the cell inhibition ability of shZNF84, indicating the involvement of Akt. Finally, the relationship between ZNF84 and Akt in vivo showed positive correlation (p = 0.023). Conclusion ZNF84 expression was increased in CC tissues and associated with tumor size. ZNF84 promoted cell proliferation which might involve Akt signal.